APO Research
Talk to an analyst

APO RESEARCH · REPORT

Synthetic Injectable Bone Graft

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Synthetic Injectable Bone Graft Market Analysis and Forecast 2026-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchSynthetic Injectable Bone Graft Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Synthetic Injectable Bone Graft Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Synthetic Injectable Bone Graft Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Synthetic Injectable Bone Graft Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Synthetic Injectable Bone Graft Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Synthetic Injectable Bone Graft market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Synthetic Injectable Bone Graft is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Synthetic Injectable Bone Graft is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Synthetic Injectable Bone Graft is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Synthetic Injectable Bone Graft is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Synthetic Injectable Bone Graft include Baxter, Zimmer Biomet, Xtant Medical, Stryker (Wright Medical), SeaSpine, ORD, Medtronic, Graftys and DePuy Synthes, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Synthetic Injectable Bone Graft, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Synthetic Injectable Bone Graft, also provides the revenue of main regions and countries. Of the upcoming market potential for Synthetic Injectable Bone Graft, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Synthetic Injectable Bone Graft revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Synthetic Injectable Bone Graft market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Synthetic Injectable Bone Graft revenue, projected growth trends, production technology, application and end-user industry.

Synthetic Injectable Bone Graft Segment by Company

Baxter

Zimmer Biomet

Xtant Medical

Stryker (Wright Medical)

SeaSpine

ORD

Medtronic

Graftys

DePuy Synthes

BONESUPPORT

Biomatlante

Biocomposites

Anika

Synthetic Injectable Bone Graft Segment by Type

Hydroxyapatite

Calcium Phosphate

Others

Synthetic Injectable Bone Graft Segment by Application

Hospital

Clinic

Synthetic Injectable Bone Graft Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Injectable Bone Graft market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Synthetic Injectable Bone Graft and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Injectable Bone Graft.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Synthetic Injectable Bone Graft in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Synthetic Injectable Bone Graft company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Synthetic Injectable Bone Graft revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Synthetic Injectable Bone Graft Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hydroxyapatite Major Player Table 3. Calcium Phosphate Major Player Table 4. Others Major Player Table 5. Global Synthetic Injectable Bone Graft Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Clinic Major Player Table 8. Synthetic Injectable Bone Graft Industry Trends Table 9. Synthetic Injectable Bone Graft Industry Drivers Table 10. Synthetic Injectable Bone Graft Industry Opportunities and Challenges Table 11. Synthetic Injectable Bone Graft Industry Restraints Table 12. Global Synthetic Injectable Bone Graft Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Synthetic Injectable Bone Graft Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Synthetic Injectable Bone Graft Market Share by Region (2021-2026) Table 15. Global Synthetic Injectable Bone Graft Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Synthetic Injectable Bone Graft Market Share by Region (2027-2032) Table 17. Global Synthetic Injectable Bone Graft Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Synthetic Injectable Bone Graft Revenue Market Share by Players (2021-2026) Table 19. Global Synthetic Injectable Bone Graft Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Synthetic Injectable Bone Graft Key Players Headquarters & Area Served Table 21. Global Synthetic Injectable Bone Graft Players, Product Type & Application Table 22. Global Synthetic Injectable Bone Graft Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Synthetic Injectable Bone Graft by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Synthetic Injectable Bone Graft Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Synthetic Injectable Bone Graft Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Synthetic Injectable Bone Graft Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Synthetic Injectable Bone Graft Revenue Market Share by Type (2021-2026) Table 29. Global Synthetic Injectable Bone Graft Revenue Market Share by Type (2027-2032) Table 30. Global Synthetic Injectable Bone Graft Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Synthetic Injectable Bone Graft Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Synthetic Injectable Bone Graft Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Synthetic Injectable Bone Graft Revenue Market Share by Application (2021-2026) Table 34. Global Synthetic Injectable Bone Graft Revenue Market Share by Application (2027-2032) Table 35. Baxter Company Information Table 36. Baxter Business Overview Table 37. Baxter Synthetic Injectable Bone Graft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Baxter Synthetic Injectable Bone Graft Product Portfolio Table 39. Baxter Recent Development Table 40. Zimmer Biomet Company Information Table 41. Zimmer Biomet Business Overview Table 42. Zimmer Biomet Synthetic Injectable Bone Graft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Zimmer Biomet Synthetic Injectable Bone Graft Product Portfolio Table 44. Zimmer Biomet Recent Development Table 45. Xtant Medical Company Information Table 46. Xtant Medical Business Overview Table 47. Xtant Medical Synthetic Injectable Bone Graft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Xtant Medical Synthetic Injectable Bone Graft Product Portfolio Table 49. Xtant Medical Recent Development Table 50. Stryker (Wright Medical) Company Information Table 51. Stryker (Wright Medical) Business Overview Table 52. Stryker (Wright Medical) Synthetic Injectable Bone Graft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Stryker (Wright Medical) Synthetic Injectable Bone Graft Product Portfolio Table 54. Stryker (Wright Medical) Recent Development Table 55. SeaSpine Company Information Table 56. SeaSpine Business Overview Table 57. SeaSpine Synthetic Injectable Bone Graft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. SeaSpine Synthetic Injectable Bone Graft Product Portfolio Table 59. SeaSpine Recent Development Table 60. ORD Company Information Table 61. ORD Business Overview Table 62. ORD Synthetic Injectable Bone Graft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. ORD Synthetic Injectable Bone Graft Product Portfolio Table 64. ORD Recent Development Table 65. Medtronic Company Information Table 66. Medtronic Business Overview Table 67. Medtronic Synthetic Injectable Bone Graft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Medtronic Synthetic Injectable Bone Graft Product Portfolio Table 69. Medtronic Recent Development Table 70. Graftys Company Information Table 71. Graftys Business Overview Table 72. Graftys Synthetic Injectable Bone Graft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Graftys Synthetic Injectable Bone Graft Product Portfolio Table 74. Graftys Recent Development Table 75. DePuy Synthes Company Information Table 76. DePuy Synthes Business Overview Table 77. DePuy Synthes Synthetic Injectable Bone Graft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. DePuy Synthes Synthetic Injectable Bone Graft Product Portfolio Table 79. DePuy Synthes Recent Development Table 80. BONESUPPORT Company Information Table 81. BONESUPPORT Business Overview Table 82. BONESUPPORT Synthetic Injectable Bone Graft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. BONESUPPORT Synthetic Injectable Bone Graft Product Portfolio Table 84. BONESUPPORT Recent Development Table 85. Biomatlante Company Information Table 86. Biomatlante Business Overview Table 87. Biomatlante Synthetic Injectable Bone Graft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Biomatlante Synthetic Injectable Bone Graft Product Portfolio Table 89. Biomatlante Recent Development Table 90. Biocomposites Company Information Table 91. Biocomposites Business Overview Table 92. Biocomposites Synthetic Injectable Bone Graft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Biocomposites Synthetic Injectable Bone Graft Product Portfolio Table 94. Biocomposites Recent Development Table 95. Anika Company Information Table 96. Anika Business Overview Table 97. Anika Synthetic Injectable Bone Graft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Anika Synthetic Injectable Bone Graft Product Portfolio Table 99. Anika Recent Development Table 100. North America Synthetic Injectable Bone Graft Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Synthetic Injectable Bone Graft Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Synthetic Injectable Bone Graft Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Synthetic Injectable Bone Graft Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Synthetic Injectable Bone Graft Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Synthetic Injectable Bone Graft Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Synthetic Injectable Bone Graft Revenue by Country (US$ Million) & (2027-2032) Table 107. Europe Synthetic Injectable Bone Graft Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Synthetic Injectable Bone Graft Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Synthetic Injectable Bone Graft Revenue by Application (2021-2026) & (US$ Million) Table 110. Europe Synthetic Injectable Bone Graft Revenue by Application (2027-2032) & (US$ Million) Table 111. Europe Synthetic Injectable Bone Graft Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Synthetic Injectable Bone Graft Revenue by Country (2021-2026) & (US$ Million) Table 113. Europe Synthetic Injectable Bone Graft Revenue by Country (US$ Million) & (2027-2032) Table 114. China Synthetic Injectable Bone Graft Revenue by Type (2021-2026) & (US$ Million) Table 115. China Synthetic Injectable Bone Graft Revenue by Type (2027-2032) & (US$ Million) Table 116. China Synthetic Injectable Bone Graft Revenue by Application (2021-2026) & (US$ Million) Table 117. China Synthetic Injectable Bone Graft Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Synthetic Injectable Bone Graft Revenue by Type (2021-2026) & (US$ Million) Table 119. Asia Synthetic Injectable Bone Graft Revenue by Type (2027-2032) & (US$ Million) Table 120. Asia Synthetic Injectable Bone Graft Revenue by Application (2021-2026) & (US$ Million) Table 121. Asia Synthetic Injectable Bone Graft Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Synthetic Injectable Bone Graft Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Synthetic Injectable Bone Graft Revenue by Region (US$ Million) & (2021-2026) Table 124. Asia Synthetic Injectable Bone Graft Revenue by Region (US$ Million) & (2027-2032) Table 125. SAMEA Synthetic Injectable Bone Graft Revenue by Type (2021-2026) & (US$ Million) Table 126. SAMEA Synthetic Injectable Bone Graft Revenue by Type (2027-2032) & (US$ Million) Table 127. SAMEA Synthetic Injectable Bone Graft Revenue by Application (2021-2026) & (US$ Million) Table 128. SAMEA Synthetic Injectable Bone Graft Revenue by Application (2027-2032) & (US$ Million) Table 129. SAMEA Synthetic Injectable Bone Graft Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. SAMEA Synthetic Injectable Bone Graft Revenue by Country (2021-2026) & (US$ Million) Table 131. SAMEA Synthetic Injectable Bone Graft Revenue by Country (US$ Million) & (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Synthetic Injectable Bone Graft Image Figure 2. Global Synthetic Injectable Bone Graft Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Synthetic Injectable Bone Graft Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hydroxyapatite Image Figure 5. Calcium Phosphate Image Figure 6. Others Image Figure 7. Global Synthetic Injectable Bone Graft Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Synthetic Injectable Bone Graft Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Global Synthetic Injectable Bone Graft Market Size (US$ Million) & (2021-2032) Figure 12. Global Synthetic Injectable Bone Graft Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Synthetic Injectable Bone Graft Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Synthetic Injectable Bone Graft Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Synthetic Injectable Bone Graft Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Synthetic Injectable Bone Graft Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Synthetic Injectable Bone Graft Revenue Market Share by Type (2021-2032) Figure 19. Global Synthetic Injectable Bone Graft Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Synthetic Injectable Bone Graft Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Synthetic Injectable Bone Graft Revenue Market Share by Application (2021-2032) Figure 22. North America Synthetic Injectable Bone Graft Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Synthetic Injectable Bone Graft Revenue Share by Type (2021-2032) Figure 24. North America Synthetic Injectable Bone Graft Revenue Share by Application (2021-2032) Figure 25. North America Synthetic Injectable Bone Graft Revenue Share by Country (2021-2032) Figure 26. United States Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Synthetic Injectable Bone Graft Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Synthetic Injectable Bone Graft Revenue Share by Type (2021-2032) Figure 31. Europe Synthetic Injectable Bone Graft Revenue Share by Application (2021-2032) Figure 32. Europe Synthetic Injectable Bone Graft Revenue Share by Country (2021-2032) Figure 33. Germany Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Synthetic Injectable Bone Graft Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Synthetic Injectable Bone Graft Revenue Share by Type (2021-2032) Figure 43. China Synthetic Injectable Bone Graft Revenue Share by Application (2021-2032) Figure 44. Asia Synthetic Injectable Bone Graft Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Synthetic Injectable Bone Graft Revenue Share by Type (2021-2032) Figure 46. Asia Synthetic Injectable Bone Graft Revenue Share by Application (2021-2032) Figure 47. Asia Synthetic Injectable Bone Graft Revenue Share by Region (2021-2032) Figure 48. Japan Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Synthetic Injectable Bone Graft Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Synthetic Injectable Bone Graft Revenue Share by Type (2021-2032) Figure 56. SAMEA Synthetic Injectable Bone Graft Revenue Share by Application (2021-2032) Figure 57. SAMEA Synthetic Injectable Bone Graft Revenue Share by Country (2021-2032) Figure 58. Brazil Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Synthetic Injectable Bone Graft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Hydroxyapatite
  • Calcium Phosphate
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Baxter
  • Zimmer Biomet
  • Xtant Medical
  • Stryker (Wright Medical)
  • SeaSpine
  • ORD
  • Medtronic
  • Graftys
  • DePuy Synthes
  • BONESUPPORT
  • Biomatlante
  • Biocomposites
  • Anika

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Synthetic Injectable Bone Graft Market by Type
  3. 1.2.1 Global Synthetic Injectable Bone Graft Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hydroxyapatite
  5. 1.2.3 Calcium Phosphate
  6. 1.2.4 Others
  7. 1.3 Synthetic Injectable Bone Graft Market by Application
  8. 1.3.1 Global Synthetic Injectable Bone Graft Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Synthetic Injectable Bone Graft Market Dynamics
  1. 2.1 Synthetic Injectable Bone Graft Industry Trends
  2. 2.2 Synthetic Injectable Bone Graft Industry Drivers
  3. 2.3 Synthetic Injectable Bone Graft Industry Opportunities and Challenges
  4. 2.4 Synthetic Injectable Bone Graft Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Synthetic Injectable Bone Graft Market Perspective (2021-2032)
  2. 3.2 Global Synthetic Injectable Bone Graft Growth Trends by Region
  3. 3.2.1 Global Synthetic Injectable Bone Graft Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Synthetic Injectable Bone Graft Market Size by Region (2021-2026)
  5. 3.2.3 Global Synthetic Injectable Bone Graft Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Synthetic Injectable Bone Graft Revenue by Players
  2. 4.1.1 Global Synthetic Injectable Bone Graft Revenue by Players (2021-2026)
  3. 4.1.2 Global Synthetic Injectable Bone Graft Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Synthetic Injectable Bone Graft Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Synthetic Injectable Bone Graft Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Synthetic Injectable Bone Graft Key Players Headquarters & Area Served
  7. 4.4 Global Synthetic Injectable Bone Graft Players, Product Type & Application
  8. 4.5 Global Synthetic Injectable Bone Graft Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Synthetic Injectable Bone Graft Market CR5 and HHI
  11. 4.6.3 2025 Synthetic Injectable Bone Graft Tier 1, Tier 2, and Tier 3
5 Synthetic Injectable Bone Graft Market Size by Type
  1. 5.1 Global Synthetic Injectable Bone Graft Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Synthetic Injectable Bone Graft Revenue by Type (2021-2032)
  3. 5.3 Global Synthetic Injectable Bone Graft Revenue Market Share by Type (2021-2032)
6 Synthetic Injectable Bone Graft Market Size by Application
  1. 6.1 Global Synthetic Injectable Bone Graft Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Synthetic Injectable Bone Graft Revenue by Application (2021-2032)
  3. 6.3 Global Synthetic Injectable Bone Graft Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Baxter
  2. 7.1.1 Baxter Company Information
  3. 7.1.2 Baxter Business Overview
  4. 7.1.3 Baxter Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Baxter Synthetic Injectable Bone Graft Product Portfolio
  6. 7.1.5 Baxter Recent Developments
  7. 7.2 Zimmer Biomet
  8. 7.2.1 Zimmer Biomet Company Information
  9. 7.2.2 Zimmer Biomet Business Overview
  10. 7.2.3 Zimmer Biomet Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Zimmer Biomet Synthetic Injectable Bone Graft Product Portfolio
  12. 7.2.5 Zimmer Biomet Recent Developments
  13. 7.3 Xtant Medical
  14. 7.3.1 Xtant Medical Company Information
  15. 7.3.2 Xtant Medical Business Overview
  16. 7.3.3 Xtant Medical Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Xtant Medical Synthetic Injectable Bone Graft Product Portfolio
  18. 7.3.5 Xtant Medical Recent Developments
  19. 7.4 Stryker (Wright Medical)
  20. 7.4.1 Stryker (Wright Medical) Company Information
  21. 7.4.2 Stryker (Wright Medical) Business Overview
  22. 7.4.3 Stryker (Wright Medical) Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Stryker (Wright Medical) Synthetic Injectable Bone Graft Product Portfolio
  24. 7.4.5 Stryker (Wright Medical) Recent Developments
  25. 7.5 SeaSpine
  26. 7.5.1 SeaSpine Company Information
  27. 7.5.2 SeaSpine Business Overview
  28. 7.5.3 SeaSpine Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  29. 7.5.4 SeaSpine Synthetic Injectable Bone Graft Product Portfolio
  30. 7.5.5 SeaSpine Recent Developments
  31. 7.6 ORD
  32. 7.6.1 ORD Company Information
  33. 7.6.2 ORD Business Overview
  34. 7.6.3 ORD Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ORD Synthetic Injectable Bone Graft Product Portfolio
  36. 7.6.5 ORD Recent Developments
  37. 7.7 Medtronic
  38. 7.7.1 Medtronic Company Information
  39. 7.7.2 Medtronic Business Overview
  40. 7.7.3 Medtronic Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Medtronic Synthetic Injectable Bone Graft Product Portfolio
  42. 7.7.5 Medtronic Recent Developments
  43. 7.8 Graftys
  44. 7.8.1 Graftys Company Information
  45. 7.8.2 Graftys Business Overview
  46. 7.8.3 Graftys Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Graftys Synthetic Injectable Bone Graft Product Portfolio
  48. 7.8.5 Graftys Recent Developments
  49. 7.9 DePuy Synthes
  50. 7.9.1 DePuy Synthes Company Information
  51. 7.9.2 DePuy Synthes Business Overview
  52. 7.9.3 DePuy Synthes Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  53. 7.9.4 DePuy Synthes Synthetic Injectable Bone Graft Product Portfolio
  54. 7.9.5 DePuy Synthes Recent Developments
  55. 7.10 BONESUPPORT
  56. 7.10.1 BONESUPPORT Company Information
  57. 7.10.2 BONESUPPORT Business Overview
  58. 7.10.3 BONESUPPORT Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  59. 7.10.4 BONESUPPORT Synthetic Injectable Bone Graft Product Portfolio
  60. 7.10.5 BONESUPPORT Recent Developments
  61. 7.11 Biomatlante
  62. 7.11.1 Biomatlante Company Information
  63. 7.11.2 Biomatlante Business Overview
  64. 7.11.3 Biomatlante Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Biomatlante Synthetic Injectable Bone Graft Product Portfolio
  66. 7.11.5 Biomatlante Recent Developments
  67. 7.12 Biocomposites
  68. 7.12.1 Biocomposites Company Information
  69. 7.12.2 Biocomposites Business Overview
  70. 7.12.3 Biocomposites Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Biocomposites Synthetic Injectable Bone Graft Product Portfolio
  72. 7.12.5 Biocomposites Recent Developments
  73. 7.13 Anika
  74. 7.13.1 Anika Company Information
  75. 7.13.2 Anika Business Overview
  76. 7.13.3 Anika Synthetic Injectable Bone Graft Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Anika Synthetic Injectable Bone Graft Product Portfolio
  78. 7.13.5 Anika Recent Developments
8 North America
  1. 8.1 North America Synthetic Injectable Bone Graft Revenue (2021-2032)
  2. 8.2 North America Synthetic Injectable Bone Graft Revenue by Type (2021-2032)
  3. 8.2.1 North America Synthetic Injectable Bone Graft Revenue by Type (2021-2026)
  4. 8.2.2 North America Synthetic Injectable Bone Graft Revenue by Type (2027-2032)
  5. 8.3 North America Synthetic Injectable Bone Graft Revenue Share by Type (2021-2032)
  6. 8.4 North America Synthetic Injectable Bone Graft Revenue by Application (2021-2032)
  7. 8.4.1 North America Synthetic Injectable Bone Graft Revenue by Application (2021-2026)
  8. 8.4.2 North America Synthetic Injectable Bone Graft Revenue by Application (2027-2032)
  9. 8.5 North America Synthetic Injectable Bone Graft Revenue Share by Application (2021-2032)
  10. 8.6 North America Synthetic Injectable Bone Graft Revenue by Country
  11. 8.6.1 North America Synthetic Injectable Bone Graft Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Synthetic Injectable Bone Graft Revenue by Country (2021-2026)
  13. 8.6.3 North America Synthetic Injectable Bone Graft Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Synthetic Injectable Bone Graft Revenue (2021-2032)
  2. 9.2 Europe Synthetic Injectable Bone Graft Revenue by Type (2021-2032)
  3. 9.2.1 Europe Synthetic Injectable Bone Graft Revenue by Type (2021-2026)
  4. 9.2.2 Europe Synthetic Injectable Bone Graft Revenue by Type (2027-2032)
  5. 9.3 Europe Synthetic Injectable Bone Graft Revenue Share by Type (2021-2032)
  6. 9.4 Europe Synthetic Injectable Bone Graft Revenue by Application (2021-2032)
  7. 9.4.1 Europe Synthetic Injectable Bone Graft Revenue by Application (2021-2026)
  8. 9.4.2 Europe Synthetic Injectable Bone Graft Revenue by Application (2027-2032)
  9. 9.5 Europe Synthetic Injectable Bone Graft Revenue Share by Application (2021-2032)
  10. 9.6 Europe Synthetic Injectable Bone Graft Revenue by Country
  11. 9.6.1 Europe Synthetic Injectable Bone Graft Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Synthetic Injectable Bone Graft Revenue by Country (2021-2026)
  13. 9.6.3 Europe Synthetic Injectable Bone Graft Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Synthetic Injectable Bone Graft Revenue (2021-2032)
  2. 10.2 China Synthetic Injectable Bone Graft Revenue by Type (2021-2032)
  3. 10.2.1 China Synthetic Injectable Bone Graft Revenue by Type (2021-2026)
  4. 10.2.2 China Synthetic Injectable Bone Graft Revenue by Type (2027-2032)
  5. 10.3 China Synthetic Injectable Bone Graft Revenue Share by Type (2021-2032)
  6. 10.4 China Synthetic Injectable Bone Graft Revenue by Application (2021-2032)
  7. 10.4.1 China Synthetic Injectable Bone Graft Revenue by Application (2021-2026)
  8. 10.4.2 China Synthetic Injectable Bone Graft Revenue by Application (2027-2032)
  9. 10.5 China Synthetic Injectable Bone Graft Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Synthetic Injectable Bone Graft Revenue (2021-2032)
  2. 11.2 Asia Synthetic Injectable Bone Graft Revenue by Type (2021-2032)
  3. 11.2.1 Asia Synthetic Injectable Bone Graft Revenue by Type (2021-2026)
  4. 11.2.2 Asia Synthetic Injectable Bone Graft Revenue by Type (2027-2032)
  5. 11.3 Asia Synthetic Injectable Bone Graft Revenue Share by Type (2021-2032)
  6. 11.4 Asia Synthetic Injectable Bone Graft Revenue by Application (2021-2032)
  7. 11.4.1 Asia Synthetic Injectable Bone Graft Revenue by Application (2021-2026)
  8. 11.4.2 Asia Synthetic Injectable Bone Graft Revenue by Application (2027-2032)
  9. 11.5 Asia Synthetic Injectable Bone Graft Revenue Share by Application (2021-2032)
  10. 11.6 Asia Synthetic Injectable Bone Graft Revenue by Country
  11. 11.6.1 Asia Synthetic Injectable Bone Graft Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Synthetic Injectable Bone Graft Revenue by Country (2021-2026)
  13. 11.6.3 Asia Synthetic Injectable Bone Graft Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Synthetic Injectable Bone Graft Revenue (2021-2032)
  2. 12.2 SAMEA Synthetic Injectable Bone Graft Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Synthetic Injectable Bone Graft Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Synthetic Injectable Bone Graft Revenue by Type (2027-2032)
  5. 12.3 SAMEA Synthetic Injectable Bone Graft Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Synthetic Injectable Bone Graft Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Synthetic Injectable Bone Graft Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Synthetic Injectable Bone Graft Revenue by Application (2027-2032)
  9. 12.5 SAMEA Synthetic Injectable Bone Graft Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Synthetic Injectable Bone Graft Revenue by Country
  11. 12.6.1 SAMEA Synthetic Injectable Bone Graft Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Synthetic Injectable Bone Graft Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Synthetic Injectable Bone Graft Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst